On Tuesday, Sagimet Biosciences Inc (NASDAQ: SGMT) opened higher 4.01% from the last session, before settling in for the closing price of $3.49. Price fluctuations for SGMT have ranged from $1.73 to $7.38 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Company’s average yearly earnings per share was noted -75.86% at the time writing. With a float of $23.62 million, this company’s outstanding shares have now reached $30.67 million.
The firm has a total of 14 workers. Let’s measure their productivity. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Sagimet Biosciences Inc (SGMT) Insider Activity
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Sagimet Biosciences Inc is 26.63%, while institutional ownership is 36.23%. The most recent insider transaction that took place on Jul 23 ’24, was worth 74,830. In this transaction Executive Chairman of this company sold 23,625 shares at a rate of $3.17, taking the stock ownership to the 118,693 shares. Before that another transaction happened on Jul 19 ’24, when Company’s Chief Medical Officer sold 8,357 for $3.10, making the entire transaction worth $25,910. This insider now owns 81,213 shares in total.
Sagimet Biosciences Inc (SGMT) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.58 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -75.86% per share during the next fiscal year.
Sagimet Biosciences Inc (NASDAQ: SGMT) Trading Performance Indicators
Check out the current performance indicators for Sagimet Biosciences Inc (SGMT). In the past quarter, the stock posted a quick ratio of 20.26.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.78, a number that is poised to hit -0.59 in the next quarter and is forecasted to reach -3.16 in one year’s time.
Technical Analysis of Sagimet Biosciences Inc (SGMT)
Analysing the last 5-days average volume posted by the [Sagimet Biosciences Inc, SGMT], we can find that recorded value of 0.79 million was better than the volume posted last year of 0.74 million. As of the previous 9 days, the stock’s Stochastic %D was 58.10%. Additionally, its Average True Range was 0.29.
During the past 100 days, Sagimet Biosciences Inc’s (SGMT) raw stochastic average was set at 49.10%, which indicates a significant decrease from 71.43% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 59.06% in the past 14 days, which was lower than the 96.31% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.09, while its 200-day Moving Average is $4.03. Now, the first resistance to watch is $3.76. This is followed by the second major resistance level at $3.90. The third major resistance level sits at $4.05. If the price goes on to break the first support level at $3.47, it is likely to go to the next support level at $3.32. Should the price break the second support level, the third support level stands at $3.18.
Sagimet Biosciences Inc (NASDAQ: SGMT) Key Stats
There are currently 30,675K shares outstanding in the company with a market cap of 111.35 million. Presently, the company’s annual sales total 0 K according to its annual income of -45,570 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -18,180 K.
